Thomas J. Kipps
University of San Diego(US)National Foundation for Cancer Research(US)UC San Diego Health System(US)University of California, San Diego(US)University of California San Diego(US)Molina Center for Energy and the Environment(US)Novel (United States)(US)Therapeutics Clinical Research(US)NovelMed Therapeutics (United States)(US)University of California San Diego Medical Center(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Monoclonal and Polyclonal Antibodies Research, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines(2008)3,178 cited
- → A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia(2005)2,408 cited
- → Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia(2015)1,861 cited
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL(2018)1,646 cited
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited